How the product works
Artesunate rapidly reduces parasite load by acting on blood-stage Plasmodium parasites. Pyrimethamine and sulphadoxine inhibit folic acid synthesis, preventing parasite replication. The combined mechanisms enhance cure rates and lower the risk of resistance.
Who is recommended for
Clinical studies and evidence
Artesunate-based combination therapies are recommended by the World Health Organization as first-line treatment for malaria. Clinical data confirm high efficacy, rapid parasite clearance, and improved outcomes compared with monotherapy.
The medication is used to eliminate parasites quickly and prevent disease progression.
The tablets are taken orally according to a physician-prescribed regimen. Artesunate and the combination tablets are administered in a specific sequence. Dosage and duration depend on clinical guidelines and patient condition.
Contraindications:
Side effects:
